ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.

The government will allocate the payment to affordable homes programmes across all four nations, including giving funding ...

The developer funds will be used to build "hundreds" of new affordable houses across England, Scotland, Wales and Northern ...

Here's why these Australian stocks could be among the best to buy and hold forever right now. Let's dig deeper into ...

Here's one S&P/ASX 300 Index (ASX: XKO) share that Stuart Bromley of Medallion Financial Group rates a buy and one that's a ...

Vifor Pharma has responded to the investigation by offering several commitments, which include a £23m payment to healthcare systems across the four nations.

Vifor Pharma has pledged to pay £23 million to the NHS after Britain’s competition watchdog raised concerns the drugs firm had been making misleading claims about the safety of a rival’s iron ...

All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August 2022 Seasoned biopharma executive, Hervé Gisserot, designated to lead ...

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss kidney disease specialist Vifor Pharma appears to be back on track.

All regulatory clearances received for the acquisition of Vifor Pharma AGSettlement of the offer is scheduled for 9 August 2022Seasoned biopharma executive, Hervé Gisserot, designated to lead the ...

All regulatory clearances received for the acquisition of Vifor Pharma AG Settlement of the offer is scheduled for 9 August 2022 Seasoned biopharma executive, H… ...

I. Vifor Pharma AG (Issuer) is hereby exempted from the following obligations until the expiry of the period of validity of the Best Price Rule pursuant to Art. 10 para. 1 of the Ordinance of the ...